Ditchcarbon
  • Contact
  1. Organizations
  2. Chiesi Farmaceutici
Public Profile
Pharmaceutical Preparation Manufacturing
IT
updated a month ago

Chiesi Farmaceutici

Company website

Chiesi Farmaceutici, a prominent player in the global pharmaceutical industry, is headquartered in Parma, Italy. Founded in 1935, the company has established a strong presence in various operational regions, including Europe, North America, and Asia. Specialising in innovative treatments for respiratory diseases, neonatology, and rare diseases, Chiesi is renowned for its commitment to research and development, which has led to several key milestones in the biopharmaceutical sector. The company’s core products, including advanced inhalation therapies and specialty medicines, are distinguished by their focus on patient-centric solutions. Chiesi Farmaceutici has garnered recognition for its sustainable practices and dedication to improving health outcomes, positioning itself as a leader in the pharmaceutical market. With a rich history and a forward-thinking approach, Chiesi continues to make significant contributions to healthcare worldwide.

DitchCarbon Score

How does Chiesi Farmaceutici's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

82

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Chiesi Farmaceutici's score of 82 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.

89%

Let us know if this data was useful to you

Chiesi Farmaceutici's reported carbon emissions

In 2024, Chiesi Farmaceutici reported total greenhouse gas emissions of approximately 1,022,663,000 kg CO2e. This includes 24,653,000 kg CO2e from Scope 1 emissions, 49,600 kg CO2e from Scope 2 emissions (market-based), and a significant 997,514,000 kg CO2e from Scope 3 emissions. In 2023, the company recorded total emissions of about 980,116,000 kg CO2e, with Scope 1 emissions at 29,906,000 kg CO2e, Scope 2 emissions (market-based) at 591,000 kg CO2e, and Scope 3 emissions at 949,619,000 kg CO2e. Chiesi has set ambitious climate commitments, aiming to achieve a 90% reduction in absolute Scope 1 and 2 emissions by 2030 from a 2019 baseline. Additionally, the company targets a 90% reduction in Scope 3 emissions from the use of sold products by 2035. These targets are aligned with the Science Based Targets Initiative (SBTi) and reflect a commitment to net-zero emissions across all scopes by 2035. The company has made notable progress, achieving a 12% reduction in Scope 1 emissions and a 96% reduction in Scope 2 emissions (market-based) compared to the 2019 baseline. Chiesi's initiatives include transitioning to renewable energy sources, which has significantly contributed to the reduction of their carbon footprint. Overall, Chiesi Farmaceutici is actively working towards substantial emissions reductions and has established a clear pathway to meet its climate goals, demonstrating leadership in sustainability within the pharmaceutical industry.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201620172018201920202021202220232024
Scope 1
18,840,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
16,872,000
00,000,000
00,000,000
00,000,000
0,000,000
0,000,000
000,000
000,000
000,000
Scope 3
-
-
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Chiesi Farmaceutici's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Chiesi Farmaceutici is in IT, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Chiesi Farmaceutici is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Curia

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Foundation Consumer Healthcare, LLC

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Diocle S.p.A.

IT
•
Real estate services (70)
Updated 10 days ago

Covis Pharma B.V.

NL
•
Real estate services (70)
Updated 10 days ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251028.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy